Shanghai, China, 15th July 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies announced today t...
Shanghai, China, May 28th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies announced today t...
Shanghai, China, May 26th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies, today announced ...
Shanghai, January 6, 2020. Elpiscience Biopharma, Ltd., a clinical-stage biopharmaceutical company announces the appointment of Steve Chin, M.D. as Chief Medical Officer. Dr. Chin brings to th...
December 28, 2019, Shanghai, China, Elpiscience Biopharma announces the completion of Series B financing of 100 million USD. The round was led by Hyfinity Investments, with participation from Tencent,...
Shanghai September 19th 2019, Elpiscience Biopharma, Ltd., a clinical stage immuno-oncology company, announced that it will present data of anti-CD39 and anti-SIRPα antibodies, 欧洲杯买球网 a...